MedTrace Logo

Transcultural and Psychometric Validation of SUSHI and HOOS-12 Scores in Patients With Coxofemoral Pathologies

NCT04470232 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-06-13

No results posted yet for this study

Summary

The management of coxofemoral pathologies is constantly increasing.

In addition to degenerative hip pathology, the orthopedic surgeon is now confronted with pathologies such as femoro-acetabular conflict, pathologies of the gluteus medius and pathologies of the labrum whose early management limits arthritis degeneration. These pathologies are mainly encountered in young subjects (\<60 years).

Self-questionnaires play an important role in understanding patients' point of view on the impact of their coxofemoral pathologies and also allow an assessment of their condition after treatment.

For the evaluation of coxofemoral pathologies in the young subject (\<60 years) the Super Simple Hip score (SUSHI-score) was developed and validated.

In the elderly subject with hip osteoarthritis, the HOOS score has the advantage of specifically measuring pain, symptoms, function and quality of life, but is made up of 40 items and is often considered rather heavy to submit. However, it has recently been simplified and the HOOS-12 (HOOS score with 12 items) has been developed and validated.

These two scores are useful in current clinical practice but they are only validated in English.

Conditions

  • Coxofemoral Pathologies

Interventions

OTHER

Self-assessment questionnaires

120 patients with coxofemoral pathologies will pass the SUSHI-score and the HOOS-12 score questionnaires. The HAGOS (Hip and Groin Score) questionnaire will be also passed by the subject, for the convergent validity.

Sponsors & Collaborators

  • Lariboisière Hospital

    collaborator UNKNOWN

  • Saint-Gregoire Private Hospital Center

    collaborator OTHER

  • University Hospital Center of Martinique

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-11
Primary Completion
2022-09-30
Completion
2023-03-31

Countries

  • France
  • Martinique

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04470232 on ClinicalTrials.gov